pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·3h ago·1 min read
save

FSMB leaders say AI not ready for independent medical licensing

Aug 3, 2026·read at STAT ↗RegulatoryNeutral

The Federation of State Medical Boards issued an opinion that artificial‑intelligence tools are not yet suitable for independent medical licensure.

The board argues that a medical license is more than a permit to provide answers; it is a legal and ethical grant tied to human judgment, professional accountability, and a duty to put patients first-requirements AI cannot currently meet.

Consequently, FSMB recommends relying on existing professional and institutional accountability structures while state‑level policy debates, pilot programs, and draft legislation continue to explore how AI should be integrated into healthcare.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Opinion: We lead the Federation of State Medical Boards. Here’s what we think about licensing AI to practice medicine”

read at STAT ↗
1,286 words · retrieved 2h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
UNIQUE2Silo Pharma, Inc.
topics
ALSType 2 Diabetes

related stories

  • 3h agoOpinion: I’m a neurologist. I’ve delivered ALS diagnoses. Then I received one myselfSTAT
  • Jul 24Amgen deploys patients to defend troubled Tavneos in FDA hearing requestBioSpace
  • Jul 17Why affirming trans identities can be critical for suicide prevention counselingSTAT
  • Jul 16Opinion: The growing fang-to-pharmacy pipelineSTAT
  • Jul 1412 ideas for tackling the U.S. alcohol epidemicSTAT